0001127602-22-013110.txt : 20220503 0001127602-22-013110.hdr.sgml : 20220503 20220503195645 ACCESSION NUMBER: 0001127602-22-013110 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220421 FILED AS OF DATE: 20220503 DATE AS OF CHANGE: 20220503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grossi Federico CENTRAL INDEX KEY: 0001720634 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 22889295 MAIL ADDRESS: STREET 1: C/O APELLIS PHARMACEUTICALS, INC. STREET 2: 6400 WESTWIND WAY, SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-04-21 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001720634 Grossi Federico C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 CHIEF MEDICAL OFFICER Common Stock 2022-04-21 4 J 0 1875 0 D 114561 D Common Stock 2022-05-02 4 S 0 2500 43.56 D 112061 D Stock Option (Right to Buy) 44.90 2022-04-21 4 J 0 11250 0 D 2031-01-27 Common Stock 11250 0 D This represents the cancellation of a PSU awards granted on 01/28/2021 that was originally reported in table I upon grant. The performance metrics were not met. This is a scheduled sale from 10B5-1 trading plan. This represents the cancellation of a performance stock option granted on 01/28/01. The performance metrics were not met. This stock option will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to the satisfaction of a specified performance condition and continued service. /s/ David Watson, attorney-in-fact for Dr. Federico Grossi 2022-05-03